Clinical trials show progress in migraine frequency, skin cancer prevention
-
1:46
Schlesinger’s Saturday Showcase (10/24)...Lots of pre-Halloween...
-
3:17
Brewers fans celebrate Game 1 World Series win across Milwaukee
-
3:09
Brewers fans arrive bright and early to American Family Field...
-
2:20
‘Life is precious’: Brewers superfan shares World Series...
-
2:12
Brewers World Series spirit takes over Milwaukee
-
1:18
Milwaukee, Tampa Bay put friendly wagers on the line for World...
-
1:00
Brewers, MLB announce donation to Milwaukee Baseball Club ahead...
-
1:09
Kerry Washington joins Women for Crowley rally in Milwaukee ahead...
-
1:46
Ballpark worker 3D-prints a ’Brewdalorian’ ahead of World...
-
1:59
Visiting bat boy for 1957 world champion Milwaukee Braves recalls...
-
0:50
Milwaukee steamfitters weld Brewers sign for World Series run
-
2:45
Topping Off Team Spirit: Wisconsin inventor creates bottle cap...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.